Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Francis Ayuk, Ibrahim Yakoub-Agha, Matthias Stelljes, Urpu Salmenniemi, Thomas Schroeder, Gesine Bug, Maria-Pilar Gallego-Hernanz, Edouard Forcade, Jakob Passweg, Maija Itala-Remes, Simona Piemontese, Jaime Sanz, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Yanmin Zhao, Mohamad Mohty, He Huang, Fabio Ciceri, Norbert Claude Gorin
{"title":"来自全球委员会和EBMT ALWP的一项研究:具有可测量残余疾病的完全缓解的成年AML患者的单倍体相同,匹配的兄弟姐妹和匹配的非亲属供体同种异体hct的比较","authors":"Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Francis Ayuk, Ibrahim Yakoub-Agha, Matthias Stelljes, Urpu Salmenniemi, Thomas Schroeder, Gesine Bug, Maria-Pilar Gallego-Hernanz, Edouard Forcade, Jakob Passweg, Maija Itala-Remes, Simona Piemontese, Jaime Sanz, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Yanmin Zhao, Mohamad Mohty, He Huang, Fabio Ciceri, Norbert Claude Gorin","doi":"10.1186/s40164-026-00827-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12180,"journal":{"name":"Experimental Hematology & Oncology","volume":"15 1","pages":""},"PeriodicalIF":17.5000,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13589360/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.\",\"authors\":\"Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Francis Ayuk, Ibrahim Yakoub-Agha, Matthias Stelljes, Urpu Salmenniemi, Thomas Schroeder, Gesine Bug, Maria-Pilar Gallego-Hernanz, Edouard Forcade, Jakob Passweg, Maija Itala-Remes, Simona Piemontese, Jaime Sanz, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Yanmin Zhao, Mohamad Mohty, He Huang, Fabio Ciceri, Norbert Claude Gorin\",\"doi\":\"10.1186/s40164-026-00827-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12180,\"journal\":{\"name\":\"Experimental Hematology & Oncology\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":17.5000,\"publicationDate\":\"2026-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13589360/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental Hematology & Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40164-026-00827-8\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Hematology & Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40164-026-00827-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.
期刊介绍:
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Experimental Hematology & Oncology publishes original work, hypothesis, commentaries and timely reviews. With open access and rapid turnaround time from submission to publication, the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.